Atlas Trials

Stage IV Uveal Melanoma AJCC v7

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IV Uveal Melanoma AJCC v7

RecordFirmDate
Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver (NCT03472586)Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2018-05-02
Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery (NCT03326258)National Cancer Institute (NCI)2018-04-20
Neoadjuvant and Adjuvant Checkpoint Blockade (NCT02519322)M.D. Anderson Cancer Center2016-02-02
Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma (NCT02363283)National Cancer Institute (NCI)2015-09-16
Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery (NCT02158520)Academic and Community Cancer Research United2013-10-18
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery (NCT01835145)National Cancer Institute (NCI)2013-07-31
Nivolumab and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma (NCT01585194)M.D. Anderson Cancer Center2012-11-29
Vorinostat in Treating Patients With Metastatic Melanoma of the Eye (NCT01587352)National Cancer Institute (NCI)2012-05-29
Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery (NCT01989572)National Cancer Institute (NCI)2000-02-23

Track Stage IV Uveal Melanoma AJCC v7 automatically

Every clearance here is in the API, with alerts when new ones post.